PuSH - Publication Server of Helmholtz Zentrum München

Li, H.* ; Furusawa, T.* ; Cavero, R.* ; Xiao, Y.* ; Chari, R.* ; Wu, X.* ; Sun, D.* ; Hartmann, O. ; Dhall, A.* ; Holewinski, R.* ; Andresson, T.* ; Karim, B.* ; Villamor-Payà, M.* ; Gallardo, D.* ; Day, C.P.* ; Pal, L.R.* ; Nair, N.U.* ; Ruppin, E.* ; Aladjem, M.I.* ; Pommier, Y.* ; Diefenbacher, M. ; Lim, J.M.* ; Levine, R.L.* ; Stracker, T.H.* ; Weyemi, U.*

Metabolic dependency mapping identifies Peroxiredoxin 1 as a driver of resistance to ATM inhibition.

Redox Biol. 80:103503 (2025)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Metabolic pathways fuel tumor progression and resistance to stress conditions including chemotherapeutic drugs, such as DNA damage response (DDR) inhibitors. Yet, significant gaps persist in how metabolic pathways confer resistance to DDR inhibition in cancer cells. Here, we employed a metabolism-focused CRISPR knockout screen and identified genetic vulnerabilities to DDR inhibitors. We unveiled Peroxiredoxin 1 (PRDX1) as a synthetic lethality partner with Ataxia Telangiectasia Mutated (ATM) kinase. Tumor cells depleted of PRDX1 displayed heightened sensitivity to ATM inhibition in vitro and in mice in a manner dependent on p53 status. Mechanistically, we discovered that the ribosomal protein RPL32 undergoes redox modification on active cysteine residues 91 and 96 upon ATM inhibition, promoting p53 stability and altered cell fitness. Our findings reveal a new pathway whereby RPL32 senses stress and induces p53 activation impairing tumor cell survival.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Atm Kinase ; Disulfide Stress ; Peroxiredoxin 1 ; Rpl32 Redox Modification ; P53 Activation; Ataxia-telangiectasia; Oxidative Damage; Dna; Tumorigenesis; Specificity; Activation
ISSN (print) / ISBN 2213-2317
e-ISSN 2213-2317
Journal Redox Biology
Quellenangaben Volume: 80, Issue: , Pages: , Article Number: 103503 Supplement: ,
Publisher Elsevier
Publishing Place Amsterdam [u.a.]
Non-patent literature Publications
Reviewing status Peer reviewed
Grants NCI Center for Cancer Research (CCR)
National Cancer Institute, National Institutes of Health
National Cancer Institute
DKH
DIP